Stratasys Ltd Stock Price, News & Analysis

Stratasys (NASDAQ: SSYS) has been named to Fast Company's World's Most Innovative Companies list for 2025, recognizing its 35+ years of leadership in advancing additive manufacturing (AM) technology.

The company's comprehensive end-to-end solutions include the F3300 industrial 3D printer, which offers enhanced speed, accuracy, and reliability for production-level manufacturing, and the new Origin Two printer for cost-effective short-run production. Their portfolio spans five polymer technologies and includes the Antero line of thermoplastics for aerospace and industrial applications.

Stratasys' integrated approach combines advanced hardware, high-performance materials, and intelligent software like GrabCAD Print Pro, enabling manufacturers to reduce production lead times, optimize part performance, and scale manufacturing beyond traditional methods' capabilities.

Stratasys (Nasdaq: SSYS) has announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the U.S. Securities and Exchange Commission (SEC). The report, containing the company's audited annual financial statements for 2024, is accessible through the SEC's website and Stratasys' investor relations portal.

Shareholders can request a free hard copy of the 2024 annual report by contacting Chief Communications Officer Yonah Lloyd. Stratasys continues to lead in additive manufacturing, providing 3D printing solutions across various industries including aerospace, automotive, consumer products, healthcare, fashion, and education. Their offerings include smart connected 3D printers, polymer materials, software ecosystem, and parts on demand services.

Stratasys (NASDAQ: SSYS) reported Q4 2024 financial results with revenue of $150.4 million, down from $156.3 million in Q4 2023. The quarter saw a GAAP net loss of $41.9 million ($0.59 per share), including a $30.1 million non-cash impairment charge, while non-GAAP net income was $8.5 million ($0.12 per share).

Full-year 2024 revenue reached $572.5 million, compared to $627.6 million in 2023, with a GAAP net loss of $120.3 million ($1.70 per share). The company maintained positive operating cash flow of $7.8 million for the year, ending with $150.7 million in cash and no debt.

Looking ahead to 2025, Stratasys projects revenue between $570-585 million, non-GAAP operating margins of 4.0-5.0%, and Adjusted EBITDA of $44.0-50.0 million. The company secured a pending $120 million investment from Fortissimo Capital, expected to close in Q2 2025.

Stratasys (SSYS) has achieved a significant milestone by receiving its first EcoVadis Silver sustainability rating, placing in the 90th percentile globally. This certification validates the company's commitment to sustainable additive manufacturing through its Mindful Manufacturing™ strategy.

The company's sustainability framework focuses on five key areas: ESG best practices implementation, operational footprint optimization, emissions quantification, value chain sustainability, and stakeholder collaboration. Under CEO Dr. Yoav Zeif's leadership, Stratasys integrates sustainability with profitability, helping customers achieve their environmental goals through advanced 3D printing solutions.

The EcoVadis assessment evaluated Stratasys' performance across four ESG pillars: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. The company's approach includes redesigning parts and machines for environmental efficiency, implementing waste hierarchy considerations, and providing transparent lifecycle analysis data to customers.

Stratasys (NASDAQ: SSYS) and Siemens Healthineers have unveiled groundbreaking research demonstrating the exceptional accuracy of 3D-printed medical imaging phantoms that replicate human anatomy. The collaboration integrates Stratasys' RadioMatrix™ materials and Digital Anatomy® technology with Siemens Healthineers' advanced algorithms.

The joint initiative creates patient-specific anatomical models that accurately replicate anatomy and pathologies, offering a scalable and cost-effective alternative to traditional phantoms and cadavers. The research showed remarkable precision with variances as low as single Hounsfield units (HU) in critical areas like grey matter and veins.

These advanced phantoms enable:

• Enhanced CT scanner calibration and performance
• Improved development of imaging algorithms
• Better training and education in radiology
• More accurate pre-surgery planning

Stratasys (NASDAQ: SSYS) announced that New York Embroidery Studio (NYES) has integrated the J850 TechStyle™ printer into its manufacturing capabilities. This integration combines traditional embroidery with 3D printing technology, enabling enhanced creativity, personalization, and sustainable manufacturing in fashion.

NYES, a leading design studio in NYC's Garment District working with renowned designers and brands, will use the printer to produce intricate designs while reducing material waste. The technology allows for on-demand manufacturing, reducing excess inventory and enabling unique, personalized designs without additional costs.

Michelle Feinberg, NYES's Owner and Creative Director, highlighted the printer's potential for high-end fashion and entertainment projects. The studio plans to host open house events in 2025 to showcase the technology's capabilities. This collaboration demonstrates Stratasys's commitment to transforming the fashion industry through innovative solutions that combine customization, creativity, and sustainability.

Stratasys (NASDAQ: SSYS) announced that its Stratasys Direct manufacturing facility in Tuscon, Arizona has achieved ISO 13485 certification, a globally recognized standard for quality management systems in medical device manufacturing. The company plans to extend this certification to its facilities in Texas and Minnesota.

The certification formally recognizes Stratasys Direct's safety, precision, and reliability in producing 3D-printed components, addressing critical regulatory requirements and enabling medical device manufacturers to scale production while accelerating innovation. The company specializes in creating complex geometries and patient-specific components that traditional manufacturing methods cannot achieve.

This certification positions 3D printing as an essential tool for the medical device industry, offering benefits such as reduced development times, highly customized components, and faster innovation compared to traditional manufacturing methods.

Stratasys (NASDAQ: SSYS) has released preliminary Q4 2024 financial results, reporting revenue between $150.1-150.5 million. The company saw sequential hardware growth but lower consumables compared to Q3 2024. Key metrics include:

- GAAP gross margin: 46.0-46.5%
- Non-GAAP gross margin: 49.4-49.7%
- GAAP operating loss: $13.3-14.4 million
- Non-GAAP operating income: $9.0-9.5 million
- GAAP net loss: $15.3-16.5 million
- Non-GAAP net income: $8.1-8.6 million
- Adjusted EBITDA: $14.2-14.6 million

Looking ahead, Stratasys expects 8% EBITDA margins for full-year 2025 at current revenue levels, with potential to reach 10% with moderate revenue growth. The company anticipates meaningful positive operating cash flow in 2025.

Stratasys (NASDAQ: SSYS) has announced a significant $120 million equity investment from Fortissimo Capital, a leading Israeli private equity fund. The investment involves the purchase of 11,650,485 newly issued ordinary shares at $10.30 per share, representing a 10.6% premium over the January 31, 2025 closing price.

Following the transaction, Fortissimo will increase its stake from 1.5% to approximately 15.5% of Stratasys' outstanding shares. The deal includes an 18-month lock-up period and standstill provisions. Fortissimo's Founding Partner, Yuval Cohen, will join Stratasys' Board of Directors upon closing, expected in Q2 2025.

The investment aims to strengthen Stratasys' balance sheet, support growth strategy execution, and capture opportunities in the additive manufacturing industry. Fortissimo can acquire up to 24.99% of shares but is to 20% voting power, with provisions for conducting a tender offer subject to shareholder approval.